Ursprung des Netzwerks ersten Grades von Jaclyn Jaffe
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Pharmaceuticals: Major | 12 | |
| Public Company | Pharmaceuticals: Major | 9 | |
| Public Company | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jaclyn Jaffe
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member | |
| NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Nebraska | College/University | Undergraduate Degree | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Executive Officer Director of Finance/CFO Comptroller/Controller/Auditor | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | General Counsel | |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Pharmaceuticals: Other | Chief Executive Officer Director of Finance/CFO | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chief Executive Officer | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Shook, Hardy & Bacon LLP
 Shook, Hardy & Bacon LLP Miscellaneous Commercial ServicesCommercial Services Shook, Hardy & Bacon LLP engages in the provision of legal services. It offers product liability, intellectual property, business litigation, public policy, and employment litigation and policy. The firm serves pharmaceutical and medical device, food, beverages and agribusiness, insurance and reinsurance, energy, and sports industries. The company was founded by Frank P. Sebree in 1889 and is headquartered in Kansas City, MO. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree | |
| Lehigh University | College/University | Undergraduate Degree | |
| Tufts University | College/University | Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| Yeshiva University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedRisk LLC (Pennsylvania)
 MedRisk LLC (Pennsylvania) Medical/Nursing ServicesHealth Services MedRisk LLC engages in the provision of managed physical medicine and diagnostic imaging services. It offers functional capacity evaluations, telerehabilitation, and other related services. The company was founded by Shelley L. Boyce in 1994 and is headquartered in King of Prussia, PA. | Medical/Nursing Services | Chairman | |
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young (Israel) Ltd. is an Israeli company that provides accounting services. The company is based in Tel Aviv, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | General Counsel | |
| American Friends of Shalva, Inc. | Corporate Officer/Principal | ||
RP Management LLC
 RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree Doctorate Degree | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Kingsbrook Partners LP
 Kingsbrook Partners LP Investment ManagersFinance Kingsbrook Partners LP is an independent hedge fund management firm headquartered in New York City. It was founded by Adam J. Chill, Scott M. Wallace and Ari J. Storch in 2009. The firm provides investment advice to high net worth clients. | Investment Managers | Founder | |
| Goizueta Business School-Emory | College/University | Undergraduate Degree | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
| ENTERA BIO LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Boys & Girls Club of Trenton & Mercer County | Director/Board Member | ||
| American Brachytherapy Society | President | ||
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| Yale School of Medicine | College/University | Doctorate Degree | |
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| Cellvation, Inc. | Chairman Director/Board Member | ||
| University of Nebraska College of Law | College/University | Graduate Degree | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
Davita Kidney Care, Inc.
 Davita Kidney Care, Inc. Medical/Nursing ServicesHealth Services DaVita Kidney Care, Inc. is an American healthcare company that provides kidney dialysis services for patients with chronic kidney failure and end-stage renal disease. The private company is based in Denver. The company operates dialysis centers across the United States and in several other countries. | Medical/Nursing Services | Corporate Officer/Principal | |
| NUVECTIS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 46 |
| Israel | 3 |
| Schweiz | 2 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 15 |
| Commercial Services | 7 |
| Finance | 6 |
| Health Services | 3 |
Operativ
| Director/Board Member | 85 |
| Corporate Officer/Principal | 59 |
| Chairman | 34 |
| Undergraduate Degree | 33 |
| Chief Executive Officer | 31 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Weiss | 25 |
| Lindsay Rosenwald | 23 |
| Neil Herskowitz | 22 |
| Jay Kranzler | 15 |
| Faith Charles | 14 |
| Miranda Toledano | 13 |
| Joseph Benesch | 12 |
| Barry Salzman | 11 |
| Scott Reines | 11 |
| Adam Chill | 11 |
| Christian Béchon | 10 |
| Curtis Oltmans | 10 |
| Michael Ryan | 9 |
| James Murphy | 8 |
| Alexandra MacLean | 8 |
- Börse
- Insiders
- Jaclyn Jaffe
- Unternehmensverbindungen
